FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Tigecycline (Tygacil) Injection
Status: Currently in Shortage
»Date first posted: 12/10/2015
»Therapeutic Categories: Anti-Infective

Expand all

Pfizer Pharmaceuticals (Reverified 03/13/2017)

Company Contact Information:
800-533-4535

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Tygacil® (tigecycline) for Injection 50mg/10ml vial (NDC 00008-4990-20) Available Available
Tygacil® (tigecycline) for Injection 50mg/5ml vial (NDC 00008-4990-02) Available Available

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English